| Natera, Inc. Common Stock | $32.0b | $264.87 | +0.7% | 250.2K | |
| Illumina Inc | $24.7b | $178.67 | -0.4% | 195.8K | |
| Labcorp Holdings Inc. | $21.3b | $268.56 | +0.8% | 42.3K | |
| QIAGEN N.V. | $7.5b | $38.84 | -0.2% | 264.3K | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $114.38 | -1.5% | 135.5K | |
| Veracyte, Inc. | $3.7b | $59.60 | +0.2% | 129.8K | |
| 10x Genomics, Inc. Class A Common Stock | $3.6b | $36.57 | +0.0% | 190.4K | |
| GeneDx Holdings Corp. Class A Common Stock | $1.5b | $69.69 | +0.2% | 88.8K | |
| NeoGenomics, Inc. | $1.4b | $13.67 | -0.2% | 217.4K | |
| Personalis, Inc. Common Stock | $1.2b | $13.21 | +2.4% | 1.0M | |
| CareDx, Inc. | $1.2b | $28.95 | +2.2% | 77.3K | |
| Opko Health Inc. | $1.1b | $1.57 | +5.0% | 1.1M | |
| Azenta, Inc. | $1.1b | $25.00 | +0.8% | 41.6K | |
| Mesa Laboratories Inc | $0.6b | $101.15 | 0.0% | 20.1K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.48 | 0.0% | 10.5K | |
| Pacific Biosciences of California, Inc. | $462.8m | $1.69 | +1.6% | 1.3M | |
| Myriad Genetics Inc | $375.0m | $5.59 | +2.0% | 128.1K | |
| Prenetics Global Limited Class A Ordinary Share | $358.7m | $19.88 | -0.7% | 10.7K | |
| Insight Molecular Diagnostics Inc. Common Stock | $200.5m | $5.67 | +2.0% | 9.7K | |
| ALPS Group Inc Ordinary Share | $126.4m | $0.62 | 0.0% | 21.5K | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $1.80 | +18.3% | 46.1M | |
| Bionano Genomics, Inc. Common Stock | $14.2m | $1.15 | +1.8% | 107.4K | |
| BioNexus Gene Lab Corp Common stock | $5.6m | $2.08 | 0.0% | 297 |